News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amid Swine Flu, Sales Of Antiviral Drugs Surging; Swine Flu Is Sweet Pill For Roche (RHHBY) And GlaxoSmithKline (GSK)


5/5/2009 6:55:15 AM

Bookmark and Share

Pharmaceutical Business Review -- GlaxoSmithKline's Relenza and Roche's Tamiflu, two of the most controversial medicines of 2002 have caught the limelight after the out break of swine flu. World Health Organization (WHO) quoted: "It has become clear that containment of the swine flu outbreak is no longer feasible." WHO has raised the alert level from 3 to 4, which signifies that the virus is potential for outbreak at community level. The tourists have been urged not to set foot on Mexican soil.



comments powered by Disqus
   
Swine Flu

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES